List of Almac patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10260097 Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent	Patent 10260097 was granted and assigned to Almac on April, 2019 by the United States Patent and Trademark Office.		Almac	United States Patent and Trademark Office	10260097	April 16, 2019
‌ US Patent 10280468 Molecular diagnostic test for predicting response to anti-angiogenic drugs and prognosis of cancer	Patent 10280468 was granted and assigned to Almac on May, 2019 by the United States Patent and Trademark Office.	Almac	Almac	United States Patent and Trademark Office	10280468	May 7, 2019
‌ US Patent 11254986 Gene signature for immune therapies in cancer	Patent 11254986 was granted and assigned to Almac on February, 2022 by the United States Patent and Trademark Office.	Almac	Almac	United States Patent and Trademark Office	11254986	February 22, 2022
‌ US Patent 10214777 Molecular diagnostic test for cancer	Patent 10214777 was granted and assigned to Almac on February, 2019 by the United States Patent and Trademark Office.	Almac	Almac	United States Patent and Trademark Office	10214777	February 26, 2019
‌ US Patent 8846864 Purification tags of synthetic peptides and proteins	Patent 8846864 was granted and assigned to Almac on September, 2014 by the United States Patent and Trademark Office.		Almac	United States Patent and Trademark Office	8846864	September 30, 2014
‌ US Patent 9850247 Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors	Patent 9850247 was granted and assigned to Almac on December, 2017 by the United States Patent and Trademark Office.	Almac Discovery Limited	Almac	United States Patent and Trademark Office	9850247	December 26, 2017